ASPR, Commerce Department to assess active pharmaceutical ingredient base to better understand pharmaceutical supply chain聽
The Administration for Strategic Preparedness and Response July 16 it will work with the Department of Commerce on an assessment of the active pharmaceutical industrial base to better understand the pharmaceutical supply chain and how it has changed since the COVID-19 pandemic. The assessment is based on a survey conducted last winter. The study will inform federal strategies and funding decisions related to the API supply chain and raise awareness of potential supply chain issues, such as the current limited domestic manufacturing capabilities and other potential issues. The study will survey more than 200 companies, including manufacturers, distributors, suppliers and customers. A answers FAQs about the project.
Related News Articles
Headline
The Food and Drug Administration July 22 released an early alert for Novum IQ large volume infusion pumps by Baxter. The company stated that the pump has鈥
Headline
Senior leaders from the U.S. Department of Health and Human Services鈥 Administration for Strategic Preparedness and Response, along with White House鈥
Headline
President Trump July 7 issued an executive order, 鈥淓xtending the Modification of the Reciprocal Tariff Rates,鈥 which extends the original July 9 reciprocal鈥
Headline
The AHA submitted a statement today to the House Energy and Commerce Subcommittee on Health for a hearing today on the health care supply chain. The AHA鈥
Headline
The Department of Health and Human Services鈥 Administration for Strategic Preparedness and Response June 5 announced it selected two locations to test an鈥
Headline
The U.S. Court of International Trade May 28 blocked a series of tariffs issued by the Trump administration under the International Emergency Economic Powers鈥